ZHENG Jianan, CHENG Yingxin, CAO Peicheng, et al. Latest Progress of Hypertonic Saline in the Treatment of Intracranial Hypertension. [J]. (12):1533-1536(2022)
DOI:
ZHENG Jianan, CHENG Yingxin, CAO Peicheng, et al. Latest Progress of Hypertonic Saline in the Treatment of Intracranial Hypertension. [J]. (12):1533-1536(2022) DOI: 10.14009/j.issn.1672-2124.2022.12.024.
Latest Progress of Hypertonic Saline in the Treatment of Intracranial Hypertension
Intracranial hypertension is mainly caused by brain edema induced by different diseases
the key points of the treatment of brain edema is to pump water from the brain tissue into the intravascular space to reduce intracranial pressure by dehydrating agents
that is osmotic pressure therapy
and the most common used dehydrating agents are mannitol and hypertonic saline. Researches suggest that hypertonic saline may have more profound and long-lasting effect in reducing intracranial hypertension compared with mannitol. Therefore
the hypertonic saline has been widely used in the treatment of clinical cerebral edema in recent years
mainly by its mechanism of altering osmolarity
improving blood rheology
circulatory system and immune regulatory. However
there are inconsistencies in the dose
frequency
concentration and administration route of hypertonic saline. This paper reviews the treatment of intracranial hypertension with hypertonic saline.